Vesselin Dimov to Clinical Trials as Topic
This is a "connection" page, showing publications Vesselin Dimov has written about Clinical Trials as Topic.
Connection Strength
0.092
-
Immunomodulators in asthma therapy. Curr Allergy Asthma Rep. 2009 Nov; 9(6):475-83.
Score: 0.053
-
Olopatadine hydrochloride ophthalmic solution for the treatment of allergic conjunctivitis. Expert Opin Pharmacother. 2017 Aug; 18(11):1137-1143.
Score: 0.023
-
Pharmacokinetic evaluation of olopatadine for the treatment of allergic rhinitis and conjunctivitis. Expert Opin Drug Metab Toxicol. 2011 Dec; 7(12):1593-9.
Score: 0.015